Advertisement
Advertisement
SOPH
SOPHiA GENETICS SA Ordinary Shares
4.77
USDSponsored
+0.05
+1.08%
Mar 26, 13:06 UTC -4
Open
SOPH Earnings Reports
Positive Surprise Ratio
SOPH beat 10 of 19 last estimates.
53%
Next Report
Date of Next Report
May 04, 2026
Estimate for Q1 26 (Revenue/ EPS)
$20.81M
/-$0.24
Implied change from Q4 25 (Revenue/ EPS)
-4.14%
/-4.00%
Implied change from Q1 25 (Revenue/ EPS)
+17.04%
/-7.69%
SOPHiA GENETICS SA Ordinary Shares earnings per share and revenue
On Mar 03, 2026, SOPH reported earnings of -0.25 USD per share (EPS) for Q4 25, missing the estimate of -0.24 USD, resulting in a -3.18% surprise. Revenue reached 21.71 million, compared to an expected 20.94 million, with a 3.69% difference. The market reacted with a -2.51% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 analysts forecast an EPS of -0.24 USD, with revenue projected to reach 20.81 million USD, implying an decrease of -4.00% EPS, and decrease of -4.14% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
KORU Medical Systems, Inc. Common Stock (DE)
Report Date
Mar 12, 2026 For Q4 25
Estimate
-Actual
-$0.01
Surprise
-
CareCloud, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.03
Actual
$0.03
Surprise
-15.97%
Nyxoah SA Ordinary Shares
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.58
Surprise
-5.51%
Health Catalyst, Inc Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.09
Actual
$0.08
Surprise
-13.79%
Neuraxis, Inc.
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.21
Actual
-$0.17
Surprise
+22.48%
Heartflow, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.17
Actual
-$0.12
Surprise
+30.31%
Heartbeam, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.13
Actual
-$0.14
Surprise
-0.72%
HeartSciences Inc. Common Stock
Report Date
Mar 16, 2026 For Q3 26
Estimate
-$0.86
Actual
-$0.63
Surprise
+27.34%
FAQ
What were SOPHiA GENETICS SA Ordinary Shares's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, SOPHiA GENETICS SA Ordinary Shares reported EPS of -$0.25, missing estimates by -3.18%, and revenue of $21.71M, 3.69% above expectations.
How did the market react to SOPHiA GENETICS SA Ordinary Shares's Q4 2025 earnings?
The stock price moved down -2.51%, changed from $4.78 before the earnings release to $4.66 the day after.
When is SOPHiA GENETICS SA Ordinary Shares expected to report next?
The next earning report is scheduled for May 04, 2026.
What are the forecasts for SOPHiA GENETICS SA Ordinary Shares's next earnings report?
Based on 5
analysts, SOPHiA GENETICS SA Ordinary Shares is expected to report EPS of -$0.24 and revenue of $20.81M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement